← FDA Drug Approvals (Drugs@FDA)

EPIVIR

NDA · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2004-11-22

Drug application

FDA Application #

NDA020564

Application type

New Drug Application

Brand name

EPIVIR

Generic name

LAMIVUDINE

Active ingredients

LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

VIIV HLTHCARE

Manufacturer

ViiV Healthcare Company

First approval

2004-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown